White Matter Microstructure and Cognitive Function in Young Women With Polycystic Ovary Syndrome

Context: Polycystic ovary syndrome (PCOS) is a disorder characterized by insulin resistance and hyperandrogenism, which leads to an increased risk of type 2 diabetes in later life. Androgens and insulin signaling affect brain function but little is known about brain structure and function in younger adults with PCOS. Objective: To establish whether young women with PCOS display altered white matter microstructure and cognitive function. Patients, interventions, and main outcome measures: Eighteen individuals with PCOS (age, 31 ± 6 y; body mass index [BMI] 30 ± 6 kg/m2) and 18 control subjects (age, 31 ± 7 y; BMI, 29 ± 6 kg/m2), matched for age, IQ, and BMI, underwent anthropometric and metabolic evaluation, diffusion tensor MRI, a technique especially sensitive to brain white matter structure, and cognitive assessment. Cognitive scores and white matter diffusion metrics were compared between groups. White matter microstructure was evaluated across the whole white matter skeleton using tract-based spatial statistics. Associations with metabolic indices were also evaluated. Results: PCOS was associated with a widespread reduction in axial diffusivity (diffusion along the main axis of white matter fibers) and increased tissue volume fraction (the proportion of volume filled by white or grey matter rather than cerebrospinal fluid) in the corpus callosum. Cognitive performance was reduced compared with controls (first principal component, t = 2.9, P = .007), reflecting subtle decrements across a broad range of cognitive tests, despite similar education and premorbid intelligence. In PCOS, there was a reversal of the relationship seen in controls between brain microstructure and both androgens and insulin resistance. Conclusions: White matter microstructure is altered, and cognitive performance is compromised, in young adults with PCOS. These alterations in brain structure and function are independent of age, education and BMI. If reversible, these changes represent a potential target for treatment.

[1]  S. Pocock,et al.  BMI and risk of dementia in two million people over two decades: a retrospective cohort study. , 2015, The lancet. Diabetes & endocrinology.

[2]  A. Anwander,et al.  Obesity Associated Cerebral Gray and White Matter Alterations Are Interrelated in the Female Brain , 2014, PloS one.

[3]  Derek K. Jones,et al.  CSF contamination contributes to apparent microstructural alterations in mild cognitive impairment , 2014, NeuroImage.

[4]  Stephen M. Smith,et al.  Permutation inference for the general linear model , 2014, NeuroImage.

[5]  H. Soininen,et al.  Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort. , 2013, Journal of Alzheimer's disease : JAD.

[6]  John A. Barry,et al.  Visual-spatial cognition in women with polycystic ovarian syndrome: the role of androgens. , 2013, Human reproduction.

[7]  Thomas R. Knösche,et al.  White matter integrity, fiber count, and other fallacies: The do's and don'ts of diffusion MRI , 2013, NeuroImage.

[8]  Rajesh Kumar,et al.  Brain axial and radial diffusivity changes with age and gender in healthy adults , 2013, Brain Research.

[9]  Haiqun Lin,et al.  Body mass index correlates negatively with white matter integrity in the fornix and corpus callosum: A diffusion tensor imaging study , 2013, Human brain mapping.

[10]  Derek K. Jones,et al.  Individual Differences in Fornix Microstructure and Body Mass Index , 2013, PloS one.

[11]  A. Leemans,et al.  Microstructural White Matter Abnormalities and Cognitive Functioning in Type 2 Diabetes , 2012, Diabetes Care.

[12]  Allan L. Reiss,et al.  White Matter Structural Differences in Young Children With Type 1 Diabetes: A Diffusion Tensor Imaging Study , 2012, Diabetes Care.

[13]  C. Currie,et al.  Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. , 2012, The Journal of clinical endocrinology and metabolism.

[14]  Sudha Seshadri,et al.  Association of Metabolic Dysregulation With Volumetric Brain Magnetic Resonance Imaging and Cognitive Markers of Subclinical Brain Aging in Middle-Aged Adults , 2011, Diabetes Care.

[15]  L. Fratiglioni,et al.  Midlife overweight and obesity increase late-life dementia risk , 2011, Neurology.

[16]  A. Ruokonen,et al.  Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS. , 2011, The Journal of clinical endocrinology and metabolism.

[17]  Karsten Mueller,et al.  Sex-Dependent Influences of Obesity on Cerebral White Matter Investigated by Diffusion-Tensor Imaging , 2010, PloS one.

[18]  Y. Reijmer,et al.  Cognitive dysfunction in patients with type 2 diabetes , 2010, Diabetes/metabolism research and reviews.

[19]  B. A. Ardekani,et al.  Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus , 2010, Diabetologia.

[20]  Fang Liu,et al.  Sex differences in the human corpus callosum microstructure: A combined T2 myelin-water and diffusion tensor magnetic resonance imaging study , 2010, Brain Research.

[21]  L. Ferrucci,et al.  Longitudinal Examination of Obesity and Cognitive Function: Results from the Baltimore Longitudinal Study of Aging , 2010, Neuroepidemiology.

[22]  R. Newcombe,et al.  Can abdominal bioelectrical impedance refine the determination of visceral fat from waist circumference? , 2009, Physiological measurement.

[23]  Stephen M. Smith,et al.  Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference , 2009, NeuroImage.

[24]  B. Tiplady,et al.  Cognitive functioning in polycystic ovary syndrome , 2007, Psychoneuroendocrinology.

[25]  B. Sherwin,et al.  Erratum to ‘‘Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women’’ [Horm. Behav. 51 (2007) 587–596] , 2007, Hormones and Behavior.

[26]  B. Sherwin,et al.  Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women , 2007, Hormones and Behavior.

[27]  B. Sherwin,et al.  Effects of the pharmacologic manipulation of testosterone on cognitive functioning in women with polycystic ovary syndrome: A randomized, placebo-controlled treatment study , 2007, Hormones and Behavior.

[28]  P. Claman Men at risk: occupation and male infertility. , 2004, Fertility and sterility.

[29]  M. Horsfield,et al.  Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging , 1999, Magnetic resonance in medicine.

[30]  P. Basser,et al.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. 1996. , 1996, Journal of magnetic resonance.

[31]  H. Buschke,et al.  Screening for dementia by memory testing , 1988, Neurology.

[32]  R. Paul,et al.  Body mass index and neurocognitive functioning across the adult lifespan. , 2013, Neuropsychology.

[33]  Jan Sijbers,et al.  ExploreDTI: a graphical toolbox for processing, analyzing, and visualizing diffusion MR data , 2009 .

[34]  Thomas E. Nichols,et al.  A related paper has been accepted for publication in NeuroImage ) , 2005 .

[35]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.

[36]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[37]  P. Basser,et al.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. , 1996, Journal of magnetic resonance. Series B.

[38]  Ricardo Azziz,et al.  0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected , 2022 .